CCL20 and Crohn disease: Serum CCL20 levels were found to be comparable between patients with active Crohn’s disease [median (Q1, Q3): 4.08 (2.86, 6.58) pg/mL] and Crohn’s disease in remission [median (Q1, Q3): 3.78 (2.23, 5.69) pg/mL, p = 0.23] as well as between patients with active ulcerative colitis [median (Q1, Q3): 3.28 (2.23, 5.54) pg/mL] and ulcerative colitis in remission [median (Q1, Q3): 3.28 (2.50, 5.21) pg/mL, p = 0.87].